Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Chromocell Therapeutics Corporation logo — Breakthroughs that break through pain and addiction

Chromocell Therapeutics Corporation

Breakthroughs that break through pain and addiction

Founded 2003 United States North Brunswick, United States 30 employees Biotechnology

General Information

Company Name Chromocell Therapeutics Corporation
Founded Year 2003
Location United States North Brunswick, United States +1
Employees 30
Industries Biotechnology
Social

Get notified when Chromocell Therapeutics Corporation moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Chromocell Therapeutics Corporation

Chromocell Corporation is a biotechnology startup with a focus on developing non-opioid, non-addictive therapeutics to address pain and associated medical conditions. The company's flagship initiative centers on selectively targeting the sodium ion channel NaV1.7 for treating chronic pain and acute eye pain. Additionally, Chromocell Corporation has developed a portfolio of novel sublingual and intranasal single-use, disposable spray devices for conditions such as mild to moderate pain, acute migraine, and nausea and vomiting related to chemotherapy, surgery, or anesthesia. Founded in 2003 and based in the United States, the company is in the clinical-stage of its development. Chromocell Corporation's novel approach to pain management to alleviate dependency on opioids positions it within the rapidly evolving landscape of healthcare and biotechnology. The company's specialized focus on targeting specific sodium ion channels for pain treatment presents a unique proposition with significant market potential. Additionally, the development of single-use, disposable spray devices caters to the growing demand for convenient and effective drug delivery systems. However, detailed information regarding the company's last investment and the involved investors is not currently available. This may present an opportunity for venture capitalists seeking to invest in innovative biotech solutions addressing critical medical needs. As Chromocell Corporation progresses through its clinical trials and expands its portfolio, it presents an attractive prospect for investors looking to support pioneering advancements in pain management and therapeutic solutions. For more consistent updates and insights into Chromocell Corporation's progress, visit www.chromocell.com or engage with the company via social media channels.

Taxonomy: clinical-stage, therapeutics, non-opioid, pain management, drug discovery, NaV1.7 channel targeting, sublingual delivery, intranasal delivery, migraine treatment, chemotherapy-induced nausea, surgical anesthesia, Chromovert technology, flavor development

No funding data available for Chromocell Therapeutics Corporation yet.

Get notified when Chromocell Therapeutics Corporation raises funding

Chromocell Therapeutics Corporation Alternatives & Competitors

Chromocell Therapeutics Corporation vs
Sustained Therapeutics
Sustained Therapeutics Canada

Delivering a novel sustained-release drug delivery platform

Seed
5 employees
Biotechnology, Health Care
Chromocell Therapeutics Corporation vs
MAXONA Pharmaceuticals
MAXONA Pharmaceuticals United States

Maxona pharmaceuticals is committed to leveraging an ex-u

Unknown
9 employees
Biotechnology, Health Care
Chromocell Therapeutics Corporation vs
Concentric Analgesics, Inc.
Concentric Analgesics, Inc. United States

Our mission is to dramatically improve the lives of patients by developing breakthrough non-opioid p...

Convertible Note
19 employees
Biotechnology, Health Care

FAQ About Chromocell Therapeutics Corporation

Breakthroughs that break through pain and addiction
Chromocell Therapeutics Corporation was founded in 2003.
Chromocell Therapeutics Corporation is headquartered in North Brunswick, United States.
Chromocell Therapeutics Corporation operates in the following industries: Biotechnology.
Chromocell Therapeutics Corporation has approximately 30 employees.
Top alternatives and competitors to Chromocell Therapeutics Corporation include Sustained Therapeutics, MAXONA Pharmaceuticals, Concentric Analgesics, Inc., Baudax Bio, Edge Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chromocell Therapeutics Corporation and Sustained Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Chromocell Therapeutics Corporation and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy